Caricamento...
Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome
Among patients with myelodysplastic syndrome (MDS) undergoing hematopoietic cell transplantation (HCT), the impact of residual pretransplant cytogenetically abnormal cells on outcomes remains uncertain. We analyzed HCT outcomes by time of transplant disease variables, including (1) blast percentage,...
Salvato in:
| Pubblicato in: | Bone Marrow Transplant |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319562/ https://ncbi.nlm.nih.gov/pubmed/26595080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2015.274 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|